This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Glaxo Group Limited. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Thierry Boyer: Innovator in Pharmaceutical Chemistry
Introduction
Thierry Boyer is a notable inventor based in Les Ulis, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of PPAR-ligands. His work has implications for various therapeutic applications.
Latest Patents
Thierry Boyer holds a patent for a process titled "Process for preparing a thiazole PPAR-ligand and polymorphs thereof." This patent describes a method of preparing a compound of formula (I), along with its pharmaceutically acceptable salts and solvates. The patent also discloses polymorphs of this compound and their use as PPAR ligands, showcasing his innovative approach to drug development.
Career Highlights
Boyer is associated with Glaxo Group Limited, a leading company in the pharmaceutical industry. His work at Glaxo has allowed him to focus on advancing research in drug formulation and development. His expertise in the field has led to the successful patenting of his innovative processes.
Collaborations
Throughout his career, Thierry Boyer has collaborated with esteemed colleagues, including Caroline Jane Day and Andrew Jonathan Whitehead. These collaborations have fostered a productive environment for innovation and research in pharmaceutical sciences.
Conclusion
Thierry Boyer is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in drug development. His patent on PPAR-ligands exemplifies his commitment to innovation in the field.